This bill mandates Medicaid coverage for continuous glucose monitors (CGMs) and related supplies for individuals diagnosed with diabetes who meet specific eligibility criteria, such as being treated with insulin or having a history of problematic hypoglycemia. To qualify for coverage, recipients must have a prescription that aligns with FDA-approved indications for the device and demonstrate that they or their caregivers have received adequate training in using the CGM. Additionally, recipients are required to participate in follow-up care with their healthcare providers at least once every six months for the first 18 months after receiving the monitor, and at least once every 12 months thereafter.

The legislation also includes provisions for the Commissioner of Human Services to apply for necessary State plan amendments or waivers to implement these changes and secure federal financial participation. It allows the commissioner to adopt rules and regulations to facilitate the bill's objectives, with the ability to file these regulations immediately for a temporary period of up to six months. Notably, the bill deletes the term "form" in relation to reimbursement claims and inserts language clarifying that providers cannot seek reimbursement from recipients for services deemed medically unnecessary. Overall, the bill aims to enhance diabetes management for Medicaid recipients by ensuring access to essential monitoring tools and ongoing medical support.